Brief Communications
Relative Resistance of Human CD4+ Memory T Cells to Suppression by CD4+CD25+ Regulatory T Cells

https://doi.org/10.1111/j.1600-6143.2011.03635.xGet rights and content
Under a Creative Commons license
open archive

Successful expansion of functional CD4+CD25+ regulatory T cells (Treg) ex vivo under good manufacturing practice conditions has made Treg-cell therapy in clinical transplant tolerance induction a feasible possibility. In animals, Treg cells home to both transplanted tissues and local lymph nodes and are optimally suppressive if active at both sites. Therefore, they have the opportunity to suppress both naïve and memory CD4+CD25 T cells (Tresp). Clinical transplantation commonly involves depleting therapy at induction (e.g. anti-CD25), which favors homeostatic expansion of memory T cells. Animal models suggest that Treg cells are less suppressive on memory, compared with naïve Tresp that mediate allograft rejection. As a result, in the context of human Treg-cell therapy, it is important to define the effectiveness of Treg cells in regulating naïve and memory Tresp. Therefore, we compared suppression of peripheral blood naïve and memory Tresp by fresh and ex vivo expanded Treg cells using proliferation, cytokine production and activation marker expression (CD154) as readouts. With all readouts, naïve human Tresp were more suppressible by approximately 30% than their memory counterparts. This suggests that Treg cells may be more efficacious if administered before or at the time of transplantation and that depleting therapy should be avoided in clinical trials of Treg cells.

Key words:

Cell therapy
human
memory T cells
naïve T cells
regulatory T cells
suppression

Abbreviations:

7AAD
7-amino-actinomycin D
ANOVA
Analysis of Variance
ANCOVA
Analysis of Covariance
CFSE
Carboxyfluoroscein diacetate succinimidyl ester
FOXP3
Forkhead box P3
HLA
Human Leukocyte Antigen
HS
Human Serum
IC50
Half maximal Inhibitory Concentration
IS
Immunosuppression
LN
Lymph node
mTOR
Mammalian Target of Rapamycin
PBMC
Peripheral Blood Mononuclear Cells
Th
helper
Treg
Regulatory T cell
Tresp
Responder T cells

Cited by (0)

Authors have contributed equally to the work